BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rissmann R, Zuiker R. Commentary on "Investigator brochures for phase I/II trials lack information on the robustness of preclinical safety studies" by Sievers et al. Br J Clin Pharmacol 2021;87:2633-4. [PMID: 33763864 DOI: 10.1111/bcp.14823] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Rissmann R, Zuiker R. Commentary on "Investigator brochures for phase I/II trials lack information on the robustness of preclinical safety studies" by Sievers et al. Br J Clin Pharmacol 2021;87:2633-4. [PMID: 33763864 DOI: 10.1111/bcp.14823] [Cited by in F6Publishing: 1] [Reference Citation Analysis]